Evaluation of Cerebrospinal Fluid Flow in Adolescent Idiopathic Scoliosis

NCT ID: NCT04760808

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-10

Study Completion Date

2022-05-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adolescent Idiopathic Scoliosis (AIS) is the most frequent spinal deformity in adolescence, but its etiology remains unknown. Recent publications suggest a link between ciliopathy and AIS. More specifically a modification of the cerebro-spinal fluid (CSF) flow by ciliary dysfunction could be at the origin of a scoliotic deformity.

This study aims to compare the CSF flow measured by magnetic resonance imaging (MRI) in an AIS group and a control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adolescent Idiopathic Scoliosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AIS group

Baseline Clinical Examination

Intervention Type DIAGNOSTIC_TEST

Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

Initial 3T MRI of the Brain and Spine

Intervention Type RADIATION

Non-injected CSF flow MRI

6-month Follow-up Clinical Examination

Intervention Type DIAGNOSTIC_TEST

Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

6-month Follow-up 3T MRI of the Brain and Spine

Intervention Type RADIATION

Non-injected CSF flow MRI

Control Group

Baseline Clinical Examination

Intervention Type DIAGNOSTIC_TEST

Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

Initial 3T MRI of the Brain and Spine

Intervention Type RADIATION

Non-injected CSF flow MRI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Baseline Clinical Examination

Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

Intervention Type DIAGNOSTIC_TEST

Initial 3T MRI of the Brain and Spine

Non-injected CSF flow MRI

Intervention Type RADIATION

6-month Follow-up Clinical Examination

Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

Intervention Type DIAGNOSTIC_TEST

6-month Follow-up 3T MRI of the Brain and Spine

Non-injected CSF flow MRI

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female subject aged 12 to \< 18 years old
* Affiliated to the French social security system
* Having signed the inform consent form
* Whose parents have given their consent


* Subject with right thoracic AIS defined by the existence of a 3D spine deformation with a frontal deviation to right dorsal convexity with a Cobb angle of at least 20°, and a rotation of at least 20°, as evidenced by the presence of a vertebral gibbosity ≥ 5° at the Bunnel scoliometer.

If the scoliosis has more than one curvature, the right chest curvature should be the greatest high (highest frontal Cobb angle)

* Subject with x-rays of total spine, face and profile under load, according to the EOS technique, dating from less than 3 months.

Exclusion Criteria

* Instability to submit to the medical follow-up of the study for psychic, social or geographical reasons
* At least 6 "cafe au lait" spots with a size ≥ 1.5 cm (may be suggestive of neurofibromatosis)
* Ligament hyperlaxity confirmed by a Beighton score \>4/9 (which may be suggestive of scoliosis secondary)
* Contraindications of a cerebro-medullary MRI: claustrophobia, foreign bodies, and ferrometallic clips of the trunk or cephalic segment, cochlear implants, stimulators and implantable cardiac defibrillators, insulin pump
* Inequality in length of the lower limbs ≥ 20 mm on clinical examination
* Subject presenting neurological signs (signs of pyramidal irritation, sensory-motor deficit, clinical signs suggestive of cerebellar pathology ...)
* Known vestibular pathology
* Taking psychotropic drugs

Additional exclusion criterion for the AIS group:

* Subject with secondary scoliosis : neurological, orthopedic, malformative...

Additional criteria for the control group:

* Subject with a scoliosis angle ≥ 10° on a photogrammetric screening assessment (optical process, non-irradiating, which allows an Morphometric evaluation of the trunk in 3D, thanks to the analysis of the trunk reliefs)
* Subject whose clinical examination shows a gibbosity measurable (\>5°) with the scoliometer of Bunnel
Minimum Eligible Age

12 Years

Maximum Eligible Age

17 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SSR pédiatrique Marc Sautelet

UNKNOWN

Sponsor Role collaborator

Lille Catholic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-François CATANZARITI, MD

Role: PRINCIPAL_INVESTIGATOR

SSR Marc Sautelet, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SSR Pédiatrique Marc Sautelet

Villeneuve-d'Ascq, Nord (59), France

Site Status

GHICL Hôpital Saint Philibert, service d'Imagerie Médicale

Lomme, Nord, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC-P0093

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.